Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | PLA2G1B | P04054 | 1/20 | 1.00 |
| ▸ | DNMT1 | P26358 | 1/20 | 1.00 |
| ▸ | BLM | P54132 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 1.00 |
| ▸ | FNTA | P49354 | 1/20 | 0.83 |
| ▸ | FNTB | P49356 | 1/20 | 0.83 |
| ▸ | PTGES | O14684 | 1/20 | 0.73 |
| ▸ | PREP | P48147 | 1/20 | 0.73 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.73 |
| ▸ | CRYAB | P02511 | 2/20 | 0.66 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.65 |
| ▸ | HMGCR | P04035 | 1/20 | 0.62 |
| ▸ | USP2 | O75604 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Anwuweizonic Acid SCHEMBL29934311 | 1.00 | MAPT (1.00) | MAPTMEN1PLA2G1BDNMT1BLM | |
| Anwuweizonic Acid SCHEMBL20990961 | 1.00 | MAPT (1.00) | MAPTMEN1PLA2G1BDNMT1BLM | |
| Anwuweizonic Acid SCHEMBL12474243 | 1.00 | MAPT (1.00) | MAPTMEN1PLA2G1BDNMT1BLM | |
| Anwuweizonic Acid SCHEMBL29934343 | 1.00 | MAPT (1.00) | MAPTMEN1PLA2G1BDNMT1BLM | |
| Anwuweizonic Acid SCHEMBL18687709 | 1.00 | MAPT (1.00) | MAPTMEN1PLA2G1BDNMT1BLM | |
| Anwuweizonic Acid SCHEMBL12474223 | 1.00 | MAPT (1.00) | MAPTMEN1PLA2G1BDNMT1BLM | |
| Anwuweizonic Acid SCHEMBL12474225 | 1.00 | MAPT (1.00) | MAPTMEN1PLA2G1BDNMT1BLM | |
| SCHEMBL899356 | 0.91 | FNTA (1.00) | MAPTMEN1PLA2G1BDNMT1BLM | |
| SCHEMBL2226302 | 0.91 | FNTA (1.00) | MAPTMEN1PLA2G1BDNMT1BLM | |
| SCHEMBL29512020 | 0.91 | FNTA (1.00) | MAPTMEN1PLA2G1BDNMT1BLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040057908-A1 | Oral compositions and use thereof | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2004-03-25 | — | — | US | claimed |
| EP-1399119-A2 | ORAL COMPOSITIONS AND USE THEREOF | University of Rochester (US) | 2004-03-24 | — | — | EP | claimed |
| WO-2002047615-A2 | ORAL COMPOSITIONS AND USE THEREOF | UNIVERSITY OF ROCHESTER (US) | 2002-06-20 | — | — | WO | claimed |
| CN-119101112-A | Kansui alkane type triterpene compound and preparation method and application thereof | 伊犁师范大学 | 2024-12-10 | — | — | CN | disclosed |
| US-20040057908-A1 | Oral compositions and use thereof | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2004-03-25 | — | — | US | disclosed |
| EP-1399119-A2 | ORAL COMPOSITIONS AND USE THEREOF | University of Rochester (US) | 2004-03-24 | — | — | EP | disclosed |
| WO-2002047615-A2 | ORAL COMPOSITIONS AND USE THEREOF | UNIVERSITY OF ROCHESTER (US) | 2002-06-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040057908-A1 | Oral compositions and use thereof | UGGT1, DPM1, B4GALT1 | MAPT 1260/4885MEN1 4615/4885PLA2G1B 3250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.